Acorah Software Products - Accounts Production19.1.200falsetrue31 August 20241 September 2023falsetrueNo description of principal activity1 September 202431 August 202531 August 202509172727Mrs Jayna Parekhiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure091727272024-08-31091727272025-08-31091727272024-09-012025-08-3109172727frs-core:CurrentFinancialInstruments2025-08-3109172727frs-bus:PrivateLimitedCompanyLtd2024-09-012025-08-3109172727frs-bus:FilletedAccounts2024-09-012025-08-3109172727frs-bus:Micro-entities2024-09-012025-08-3109172727frs-bus:AuditExempt-NoAccountantsReport2024-09-012025-08-3109172727frs-bus:Director12024-09-012025-08-31091727272023-08-31091727272024-08-31091727272023-09-012024-08-3109172727frs-core:CurrentFinancialInstruments2024-08-31
Registered number: 09172727
JNP Pharma Limited
Unaudited Financial Statements
For The Year Ended 31 August 2025
JNP Pharma Limited
Balance Sheet
As At 31 August 2025
Balance Sheet
Registered number: 09172727
2025
2024
£
£
Creditors: Amounts Falling Due Within One Year
(1,114)
(964)
NET CURRENT LIABILITIES
(1,114)
(964)
TOTAL ASSETS LESS CURRENT LIABILITIES
(1,114)
(964)
NET LIABILITIES
(1,114)
(964)
CAPITAL AND RESERVES
(1,114)
(964)
Notes
1.General Information
JNP Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09172727. The registered office is 20, Wentworth Park, London, N3 1YG.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
11
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.